# Efficacy and Safety of Portable Hydrogen Rich Water Machine is Used for Adjuvant Treatment of Patients With Hyperlipidemia

Study · id `cardio:ct-nct06301451` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06301451](<https://clinicaltrials.gov/study/NCT06301451>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06301451

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT06301451. Randomized; no masking; primary purpose treatment. Start 2022-04-01 (actual); primary completion 2024-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT06301451, source copy `cardio:ctgov-nct06301451-2024-03-08`, retrieved 2026-10-31)
- Started: 2022-04-01 (actual) (ClinicalTrials.gov record NCT06301451, source copy `cardio:ctgov-nct06301451-2024-03-08`, retrieved 2026-10-31)
- Primary completion: 2024-12-01 (anticipated) (ClinicalTrials.gov record NCT06301451, source copy `cardio:ctgov-nct06301451-2024-03-08`, retrieved 2026-10-31)
- Completion: 2024-12-01 (anticipated) (ClinicalTrials.gov record NCT06301451, source copy `cardio:ctgov-nct06301451-2024-03-08`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT06301451, source copy `cardio:ctgov-nct06301451-2024-03-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06301451-2024-03-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Efficacy and Safety of Portable Hydrogen Rich Water Machine is Used for Adjuvant Treatment of Patients With Hyperlipidemia
- Condition: Hyperlipidemias
- Intervention (Device): General dietary guidance and hydrogen water prepared by portable hydrogen rich water machine
- Lead sponsor: Sun Jia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)

## Provenance

Content hash: 0fecca5bb21bb0da2a43aabe6a896a69c38f3b98c318535f5cdccce7ade50c73
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
